Variable,All Patients,SARS-Cov-2 Positive (C19+),Macula and C19+,Complement Def. and C19+,Coagulation and C19+,Hypertension and C19+,Type 2 Diabetes and C19+,Obesity and C19+,Coronary Artery Disease and C19+,Age Over 65,Cough (Neg Control) and C19
Intub HR (95% CI) / Univar.,,,2.2 (1.3-3.7)**,0.0 (0.0-inf),1.4 (1.1-1.7)**,1.8 (1.5-2.1)***,1.9 (1.5-2.4)***,1.3 (1.0-1.7)*,1.5 (1.2-1.8)***,1.7 (1.4-2.0)***,1.5 (1.1-1.9)**
Intub HR (95% CI) / Age & Sex Corr.,,,1.8 (1.1-3.2)*,0.0 (0.0-inf),1.3 (1.1-1.6)**,1.6 (1.3-1.9)***,1.7 (1.3-2.1)***,1.5 (1.1-1.9)**,1.3 (1.1-1.6)**,1.3 (1.0-1.8),1.4 (1.1-1.8)**
Death HR (95% CI) / Univar.,,,3.4 (2.2-5.1)***,0.0 (0.0-inf),2.2 (1.9-2.7)***,3.7 (3.2-4.4)***,3.2 (2.7-3.8)***,1.7 (1.4-2.1)***,3.2 (2.7-3.8)***,9.5 (7.5-11.9)***,1.3 (1.0-1.6)*
Death HR (95% CI) / Age & Sex Corr.,,,1.7 (1.1-2.5)*,0.0 (0.0-inf),1.7 (1.4-2.0)***,2.3 (1.9-2.7)***,2.1 (1.7-2.5)***,1.9 (1.5-2.4)***,1.9 (1.6-2.2)***,1.8 (1.3-2.4)***,1.3 (1.0-1.7)*
